Tommaso Panni

Bad Homburg Vor Der Hoehe, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Biologic dose escalation in inflammatory bowel disease in the United States.

Biologic dose escalation in inflammatory bowel disease in the United States.

Journal: Journal of managed care & specialty pharmacy

Published: February 27, 2026

Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.

Impact of moderate-to-severe ulcerative colitis and Crohn's disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey.

Journal: Current medical research and opinion

Published: July 10, 2025

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration.

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration.

Journal: Advances in therapy

Published: May 05, 2025

Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey.

Broad Impact of Bowel Urgency in Ulcerative Colitis and Crohn's Disease: US, European, and Japanese Patient and Healthcare Professional Perspectives from the Communicating Needs and Features of IBD Experiences (CONFIDE) Survey.

Journal: Advances in therapy

Published: May 02, 2025

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.

Journal: Rheumatology advances in practice

Published: October 17, 2024

US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey.

US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey.

Journal: Crohn's & colitis 360

Published: August 21, 2024

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis.

Early clinical response associates with long-term outcomes with ixekizumab in radiographic axial spondyloarthritis.

Journal: RMD open

Published: April 15, 2024

Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.

Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.

Journal: Digestive diseases and sciences

Published: February 07, 2024

Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.

Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.

Journal: Inflammatory bowel diseases

Published: January 02, 2024

Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.

Acute Treatment Patterns, Migraine Burden, and Healthcare Resource Use in People With Migraine: Results From the OVERCOME (EU) Observational Study.

Journal: Pain and therapy

Published: December 06, 2023

Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.

Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study.

Journal: The journal of headache and pain

Published: October 20, 2023

A 3-year follow-up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims-based cohort study in the United States.

A 3-year follow-up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims-based cohort study in the United States.

Journal: Headache

Published: October 15, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026